Fluorescent and electrochemical detection of nuclease activity associated with Streptococcus pneumoniae using specific oligonucleotide probes

( ) represents a significant pathogenic threat, often responsible for community-acquired pneumonia with potentially life-threatening consequences if left untreated. This underscores the pressing clinical need for rapid and accurate detection of this harmful bacteria. In this study, we report the screening and discovery of a novel biomarker for detection. We used nucleases as biomarker and we have identified a specific oligonucleotide that works as substrate. This biomarker relies on a specific nuclease activity found on the bacterial membrane, forming the basis for the development of both fluorescence and electrochemical biosensors. We observed an exceptionally high sensitivity in the performance of the electrochemical biosensor, detecting as low as 10 CFU mL , whereas the fluorescence sensor demonstrated comparatively lower efficiency, with a detection limit of 10 CFU mL . Moreover, the specificity studies have demonstrated the biosensors' remarkable capacity to identify from other pathogenic bacteria. Significantly, both biosensors have demonstrated the ability to identify cultured from clinical samples, providing compelling evidence of the potential clinical utility of this innovative detection system.